Introduction: The “Grey Area” of PGT-A Results
For many couples embarking on an IVF journey in London, the goal of genetic testing is to find a definitive answer. Historically, Preimplantation Genetic Testing for Aneuploidies (PGT-A) was viewed as a binary choice: an embryo was either “euploid” (chromosomally normal) or “aneuploid” (abnormal). However, as genomic technology has advanced in precision, we have discovered a complex middle ground known as Embryo Mosaicism.
Receiving a report that mentions Embryo Mosaicism can feel like entering a biological “grey area.” It suggests that the embryo is neither purely healthy nor purely abnormal, but rather a mixture of both. This is now a frequent and significant challenge in modern IVF, requiring expert interpretation to navigate successfully. At London Genetics, we specialise in providing clarity through this uncertainty. By integrating the latest research into our Reproductive Genetics services, we help prospective parents understand what Embryo Mosaicism means for their specific case, transforming a confusing lab result into a well-informed clinical path forward.
What is Embryo Mosaicism?
Embryo Mosaicism arises during the earliest days of embryonic development,
when a fertilised egg begins dividing into multiple cells.
Unlike embryos where all cells are genetically identical,
mosaic embryos contain a mixture of chromosomally normal and abnormal cells—
creating a unique and clinically significant biological spectrum.
In a euploid embryo, every dividing cell carries the correct
number of 46 chromosomes, creating a uniform and stable genetic blueprint.
In contrast, a fully aneuploid embryo experiences an error at the very first division,
meaning all cells carry a chromosomal abnormality.
Embryo Mosaicism occurs when a chromosomal error happens
after the first few cell divisions rather than at fertilisation.
The result is a “patchwork” embryo containing both healthy (euploid)
cells and cells with chromosomal variations.
Aneuploid embryos typically fail to implant or result in miscarriage,
as every cell carries the same chromosomal error.
Mosaic embryos occupy a distinct category of potential viability,
as healthy cells may outcompete abnormal ones,
or abnormalities may be confined to placental tissue rather than the foetus.
Key Takeaway:
Embryo Mosaicism is not a single diagnosis but a snapshot of a developing embryo in transition.
By understanding the genetic distinction between mosaic and aneuploid embryos,
clinicians and patients gain a more nuanced view of reproductive potential—
recognising that viability exists on a spectrum rather than as a simple yes-or-no outcome.
Low-Level vs. High-Level Mosaicism: Decoding the Percentages
When you receive a report detailing Embryo Mosaicism, the most vital piece of data is the “percentage of mosaicism.” This figure represents how many of the cells sampled during the biopsy were found to be abnormal. In the world of Reproductive Genetics, we use these percentages to stratify risk and determine the likelihood of a successful, healthy pregnancy.
The scientific consensus suggests that embryos with a lower percentage of abnormal cells—known as “Low-Level Mosaicism”—behave much more like healthy embryos than those with high percentages. Understanding these thresholds is essential for managing expectations during your IVF & Genetics journey.
Understanding the Risk Spectrum
To help you navigate these complex results, the following table breaks down the categories of Embryo Mosaicism and their typical clinical implications:
| Embryo Classification | % of Abnormal Cells | Clinical Interpretation | Priority for Transfer |
| Euploid (Normal) | < 20% | Considered genetically healthy with optimal success rates. | Highest Priority |
| Low-Level Mosaic | 20% – 40% | Good potential for a healthy birth; often “self-corrects.” | Secondary Option |
| High-Level Mosaic | 40% – 80% | Increased risk of miscarriage or non-implantation. | Lower Priority |
| Aneuploid (Abnormal) | > 80% | Not recommended for transfer; severe genetic risk. | Not Recommended |
It is important to remember that these percentages are based on a biopsy of the “trophectoderm” (the cells that eventually form the placenta). Because the biopsy only takes a small sample, the Genetics of Embryo Mosaicism can sometimes be more complex than a single number suggests. However, this data remains our best tool for ranking embryos in a way that maximises your chances of a successful birth while minimising the risk of Recurrent Pregnancy Loss.
Can a Mosaic Embryo Lead to a Healthy Baby?
One of the most important advances in modern fertility science
is the recognition that Embryo Mosaicism is not a definitive barrier to a healthy pregnancy.
Large-scale clinical data now confirm that mosaic embryos can—and often do—
result in the birth of healthy, genetically normal babies.
Hover over each box to understand how mosaic embryos can progress to healthy births.
A key reason mosaic embryos can succeed is a biological process
known as self-correction.
As the embryo grows, natural developmental mechanisms
can reduce or eliminate chromosomally abnormal cells,
allowing healthy cells to dominate.
Healthy (euploid) cells may divide more rapidly,
gradually outnumbering abnormal cells within the embryo.
Alternatively, abnormal cells may undergo selective apoptosis,
or become confined to placental tissue rather than forming the foetus itself.
While success rates are lower than those of fully euploid embryos,
low-level mosaic embryos show healthy birth rates
of approximately 30–50% in recent studies.
For many patients—especially those with limited embryos—
mosaic results represent a realistic, evidence-based path to parenthood.
Key Takeaway:
Embryo Mosaicism exists on a biological spectrum.
Although risks are slightly higher than with fully euploid embryos,
mosaic embryos are far from non-viable.
With expert interpretation and appropriate clinical guidance,
these “grey-area” results can offer genuine hope
and a scientifically supported opportunity for a healthy birth.
Genetic Risks and Pregnancy Outcomes
While the potential for a healthy birth is real, it is vital to acknowledge that Embryo Mosaicism does carry specific clinical risks that differ from those of a fully euploid embryo. The primary concern in Reproductive Genetics is how these abnormal cells might affect the progression of the pregnancy and the eventual health of the child.
The most common risk associated with Embryo Mosaicism is a higher rate of implantation failure or Recurrent Pregnancy Loss. If the abnormal cell line is prevalent in the tissues that form the placenta, it can lead to “placental insufficiency,” which might hinder the baby’s growth or cause complications such as pre-eclampsia later in the pregnancy.
Potential Developmental Implications
Beyond the risk of miscarriage, there are two rare but important outcomes to consider when dealing with Embryo Mosaicism:
-
Confined Placental Mosaicism (CPM): This is often a “best-case” risk scenario where the abnormal cells are restricted solely to the placenta. While the baby is genetically healthy, CPM requires closer monitoring of foetal growth throughout the third trimester.
-
Uniparental Disomy (UPD): In rare instances of “self-correction,” an embryo might end up with two chromosomes from one parent and none from the other. This can lead to specific developmental or growth-related disorders.
Understanding the Genetics of Embryo Mosaicism means preparing for a pregnancy that may require “higher-tier” screening, such as non-invasive prenatal testing (NIPT) or amniocentesis, to confirm that the foetus has indeed developed from the healthy cell line. By identifying these risks early, we can create a management plan that provides the highest level of safety for both mother and child.
The Importance of Expert Genetic Counselling
Deciphering a report that identifies Embryo Mosaicism is not a task for a standard algorithm; it requires the nuanced eye of a specialist. Because these results exist in a biological “grey area,” the expertise of a consultant like Dr Ehsan Ghayoor Karimani becomes the most critical asset in your IVF & Genetics journey. Genetic counselling is not merely about explaining the numbers; it is about assessing the specific chromosomal involvement and what that means for your future child’s health.
The “Ranking” Strategy for Embryo Transfer
When multiple embryos are available, we don’t simply choose one at random. Under the guidance of Dr Karimani, we create a bespoke “Priority Ranking” based on the latest international guidelines for Embryo Mosaicism. This involves:
-
Chromosome Assessment: Not all chromosomes are equal. Some mosaicisms (e.g., involving chromosomes 13, 18, or 21) carry higher clinical risks, while others are considered “low-risk” for transfer.
-
Level of Mosaicism: We prioritise “Low-Level” mosaics over “High-Level” ones, as the statistical probability of a healthy live birth is significantly higher.
-
Type of Error: We distinguish between “segmental” mosaicism (affecting only a piece of a chromosome) and “whole-chromosome” mosaicism to refine our success predictions.
By integrating these factors, we provide a structured roadmap. If no perfectly “euploid” embryos are present, this ranking system allows us to select the mosaic embryo with the highest potential for self-correction and a healthy outcome. This level of precision is the hallmark of the Reproductive Genetics care we provide in London—turning a source of anxiety into a calculated, scientific strategy for success.
Conclusion: Making an Informed Decision in London
Navigating Embryo Mosaicism can be one of the most challenging aspects of modern fertility treatment.
However, a mosaic result is far from a dead end. With the right scientific approach,
it can become a viable pathway to a healthy pregnancy.
Understanding the data provided by Reproductive Genetics transforms uncertainty into clarity.
With specialist guidance, you can:
- Understand the spectrum from low-level to high-level mosaic variations
- Recognise the potential of “self-correction” in embryos
- Develop a confident clinical plan for embryo transfers
From Uncertainty to Empowered Choice:
– Gain clarity on how Embryo Mosaicism impacts your specific IVF outcomes.
– Move beyond complex lab reports with expert interpretation.
– Make informed decisions focused on achieving healthy live births.
Why Expert Guidance Matters:
Every embryo is unique, and decisions about mosaic embryos require the latest genomic insight
combined with personalised clinical expertise. In London, you have access to world-class specialists
to navigate these “grey areas” safely and effectively.
Your Next Step:
Don’t let a complex PGT report stand in the way of your parenthood goals.
Book a specialist consultation with Dr Ehsan Ghayoor Karimani and the London Genetics team
to gain clarity, confidence, and a roadmap tailored to your family’s needs.
